Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

Sponsor
Creighton University (Other)
Overall Status
Completed
CT.gov ID
NCT01592539
Collaborator
(none)
78
1
15
5.2

Study Details

Study Description

Brief Summary

The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    78 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
    Study Start Date :
    May 1, 2012
    Actual Primary Completion Date :
    Aug 1, 2013
    Actual Study Completion Date :
    Aug 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Case

    Patients with Type 1 Diabetes Mellitus

    Control

    Age and sex matched healthy controls.

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      19 Years to 50 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Must have completed a previous study.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Creighton University Omaha Nebraska United States 68131

      Sponsors and Collaborators

      • Creighton University

      Investigators

      • Principal Investigator: Laura AG Armas, MD, Creighton University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Laura Armas, Assistant Professor, Creighton University
      ClinicalTrials.gov Identifier:
      NCT01592539
      Other Study ID Numbers:
      • Creighton11
      First Posted:
      May 7, 2012
      Last Update Posted:
      Feb 26, 2015
      Last Verified:
      Feb 1, 2015
      Keywords provided by Laura Armas, Assistant Professor, Creighton University
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 26, 2015